SPEAR UltraDetect™ NF-L
Spear Bio | Catalog # SPR90004
Spear Assays
Successive Proximity Extension Amplification Reaction (SPEAR) technology overcomes the limitations of conventional proximity extension assays and dramatically reduces transient noise to achieve ultra-sensitive biomarker detection. This technology delivers rapid, precise, and reproducible results with minimal sample volume. SPEAR immunoassays employ a simple and scalable workflow, easily adopted by any lab utilizing standard qPCR.
Key Product Details
Sample Type & Volume Required Per Well
Sensitivity
Assay Range
Product Summary for SPEAR UltraDetect™ NF-L
Product Specifications
Reactivity
Specificity
Cross-reactivity
Interference
Sample Values
| Sample Type (donors) | Mean Conc. (range) | Above LLoD % | Above LLoQ % |
| EDTA plasma (10 donors) | 6.23 pg/mL (2.70 - 12.8) | 100% | 100% |
| Serum (10 donors) | 6.08 pg/mL (3.20 - 10.0) | 100% | 100% |
| Heparin plasma* (10 donors) | 5.47 pg/mL (2.20 - 11.3) | 100% | 100% |
| CSF* (12 donors) | 2144 pg/mL (42.6 - 9488) | 100% | 100% |
Precision
EDTA Plasma
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 6 | 6 | 6 | 6 | 6 | 6 |
| Mean (pg/mL) | 7.24 | 133 | 344 | 7.24 | 133 | 344 |
| Standard Deviation | ||||||
| CV% | 4.4 | 2.6 | 2.5 | 6.4 | 5.3 | 4.5 |
Serum
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 6 | 6 | 6 | 6 | 6 | 6 |
| Mean (pg/mL) | 6.07 | 56.5 | 451 | 6.07 | 56.5 | 451 |
| Standard Deviation | ||||||
| CV% | 4.2 | 4.1 | 2.2 | 6.3 | 5.8 | 3.3 |
Recovery for SPEAR UltraDetect™ NF-L
Recovery
| Sample Type | Average % Recovery | Range % |
|---|---|---|
| EDTA Plasma (n=3) | 95 | 85-108 |
| Serum (n=3) | 98 | 81-112 |
Linearity
To assess the accuracy of the assay, EDTA Plasma and Serum from apparently healthy donors were spiked with CSF and serially diluted 2x to 32x above assay MRD. Percent recovery was calculated as the sample concentration at higher dilution divded by the sample concentration at MRD.
Preparation and Storage
Shipping
Stability & Storage
Background: NF-L
Neurofilaments are intermediate filaments that are major components of the neuronal cytoskeleton. Neurofilaments are composed of three subunits: the heavy subunit (NF-H), medium subunit (NF-M), and light subunit (NF-L). Neurofilaments are trimers that always contain the 68 kDa NF-L and variably contain 125 kDa NF-M and 200 kDa NF-H. The human neurofilament heavy chain is a phosphorylated cytoskeletal intermediate filament protein that is expressed in neurons. The neurofilament medium subunit Human NF-M is a phosphorylated glycoprotein that belongs to the type IV intermediate filament family. NF-L is a 68 kDa light chain cytoskeletal intermediate filament protein that associates with the 125 kDa NF-M and the 200 kDa NF-H to form neurofilaments.
All three neurofilament subunits share a common structure, with globular head, alpha-helical rod, and carboxy terminal side-arm domains. The subunits assemble to form 10 nm neurofilaments. Accumulation of neurofilaments is seen in several human diseases including amyotrophic lateral sclerosis (ALS), Parkinsons disease, Alzheimers disease, and diabetic neuropathy.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
Additional NF-L Products
Product Documents for SPEAR UltraDetect™ NF-L
Product Specific Notices for SPEAR UltraDetect™ NF-L
For research use only